Categories: News

Ford Hutman Media Establishes Advisory Panel

The Panel Advisors Bring a Wealth of Expertise to the Life-Science Strategic Communications Firm

SAN DIEGO–(BUSINESS WIRE)–#healthcarePRFord Hutman Media (FHM), an industry-leading, life science-focused strategic communications firm, announced the establishment of the Ford Hutman Media Advisory Panel including the appointments of five industry experts that will serve as strategic advisors.

Rachel Ford Hutman will serve as chair of the Advisory Panel. The Advisory Panel includes:

  • Dr. Alain Baron: Dr. Baron is a physician-scientist, experienced biotech chief executive officer, board member, strategic advisor and consultant. He has launched several biotech startups, including Elcelyx Therapeutics and Escient Pharmaceuticals. He was also a professor of Medicine and the head of the Department of Endocrinology and Metabolism at Indiana University.
  • Lance Friedmann: Friedmann is a marketing industry expert with vast leadership experience. He spent most of his career at Kraft Foods, where he served as Senior Vice President, marketing. He previously worked for General Foods and HBO. He holds an M.B.A. from Harvard University School of Business and an economics degree from Stanford University.
  • Chris Haddon: Haddon is a private lender, investor, marketer, author and entrepreneur. He is a principal and co-founder of Hard Money Bankers, LLC.
  • Jen Carroll: Carroll is the founder and owner of the management consulting firm Yellow Picnic Table. She is a communications expert with vast experience in the precision health space and has held communications leadership roles at Illumina and PacBio.
  • Ryan Flinn: Flinn is the head of communications for Resilience; he previously worked as a biotech journalist for Bloomberg News and has been published in The New York Times, The San Francisco Chronicle and BusinessWeek.

“These individuals have a wide range of expertise – from starting successful biotech businesses to directing marketing and communications efforts at large corporations – and I’m honored that these individuals, who are at the top of their game, are joining us as we continue to expand our presence in the life-sciences media space,” said Rachel Ford Hutman, founder and chief executive officer, Ford Hutman Media. “I’m confident that their experience and counsel will serve FHM well as we strive to provide best-in-class PR services to our current and future clients.”

The advisory panel is being established as the agency enters its third year of business with the goal to provide development guidance as the company continues to expand. Advisory panelists will also be resources for FHM executives, providing unbiased insights and trusted experience to help shape the future of FHM.

“As the founder of several biotech startups, I’ve overcome many of the challenges that businesses experience in their first years of operation. I admire that FHM created a panel to learn from seasoned business leaders,” said Dr. Baron. “As part of the advisory panel, I look forward to helping Rachel and her team achieve their next phase of development. I’m confident that their existing business acumen combined with the counsel of this advisory panel will ensure continued success and sustainable growth for FHM.”

About Ford Hutman Media

Ford Hutman Media (FHM) was created to provide industry-leading communications strategies, media relations and thought leadership to elite biotech, digital health, diagnostics and medical technology companies. FHM clients range from venture-backed startups to large cap public companies in the U.S. and Europe. Led by senior communications professionals who have spent their careers both in-house at industry-leading companies and some of the most reputable healthcare public relations agencies, FHM excels at developing unique and tailored communications approaches for our clients based on their business objectives. Learn more at FordHutmanMedia.com or follow us on Twitter @FordHutmanMedia.

Contacts

Kristan Curren

kristan@fordhutmanmedia.com
206.290.7866

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

8 hours ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

8 hours ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

8 hours ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

8 hours ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

8 hours ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

8 hours ago